Stifel analyst Jonathan Block raised the firm’s price target on Idexx Laboratories (IDXX) to $510 from $460 and keeps a Hold rating on the shares after revisiting Q1 earnings reports across the analyst’s Animal Health, Dental and Sleep Apnea coverage.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on IDXX:
- IDEXX Laboratories Updates Corporate Governance Structure
- Idexx Laboratories: Resilience and Growth Potential Amidst Challenging Conditions
- IDEXX Laboratories Reports Strong Q1 2025 Results
- IDEXX Laboratories’ Earnings Call: Strong Growth Amid Challenges
- Idexx Laboratories: Promising Developments Balanced by Market Challenges Leading to Hold Rating